These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9547438)

  • 21. Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory?
    de Lorgeril M
    World Rev Nutr Diet; 2009; 100():80-89. PubMed ID: 19696530
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
    Ballantyne CM; Olsson AG; Cook TJ; Mercuri MF; Pedersen TR; Kjekshus J
    Circulation; 2001 Dec; 104(25):3046-51. PubMed ID: 11748098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [One more (conclusive?) confirmation of ineffectiveness of antioxidant vitamins for prevention of coronary heart disease].
    Gratsiansky NA
    Kardiologiia; 2002; 42(2):85-6. PubMed ID: 12494214
    [No Abstract]   [Full Text] [Related]  

  • 24. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
    Haffner SM
    Diabetes Care; 1997 Apr; 20(4):469-71. PubMed ID: 9096961
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.
    Pedersen TR; Kjekshus J; Berg K; Haghfelt T; Faergeman O; Faergeman G; Pyörälä K; Miettinen T; Wilhelmsen L; Olsson AG; Wedel H;
    Atheroscler Suppl; 2004 Oct; 5(3):81-7. PubMed ID: 15531279
    [No Abstract]   [Full Text] [Related]  

  • 26. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

  • 27. Statin therapy for prevention of coronary artery disease with average cholesterol levels.
    Gambhir DS
    Indian Heart J; 1999; 51(1):19-20, 105. PubMed ID: 10327772
    [No Abstract]   [Full Text] [Related]  

  • 28. In brief: Ezetimibe/simvastatin (Vytorin) in chronic kidney disease.
    Med Lett Drugs Ther; 2012 Jan; 54(1381):4. PubMed ID: 22233589
    [No Abstract]   [Full Text] [Related]  

  • 29. Profiling a landmark clinical trial: Scandinavian Simvastatin Survival Study.
    Guptha S
    Curr Opin Lipidol; 1995 Oct; 6(5):251-3. PubMed ID: 8520845
    [No Abstract]   [Full Text] [Related]  

  • 30. [The SHARP study].
    Bianchi S; Gaspardone A
    G Ital Cardiol (Rome); 2013 Feb; 14(2):87-91. PubMed ID: 23389310
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
    Tikkanen MJ; Holme I; Cater NB; Szarek M; Faergeman O; Kastelein JJ; Olsson AG; Larsen ML; Lindahl C; Pedersen TR;
    Am J Cardiol; 2009 Mar; 103(5):577-82. PubMed ID: 19231315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Letter].
    Poli A
    G Ital Cardiol (Rome); 2015 Dec; 16(12):739-40. PubMed ID: 26667952
    [No Abstract]   [Full Text] [Related]  

  • 33. [Advance in clinical studies on atherosclerosis].
    Yokode M
    Nihon Ronen Igakkai Zasshi; 2000 Mar; 37(3):202-6. PubMed ID: 10879067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The IMPROVE-IT trial].
    Menozzi A; Lina D; Urbinati S; Greco C
    G Ital Cardiol (Rome); 2015 Dec; 16(12):667-71. PubMed ID: 26667942
    [No Abstract]   [Full Text] [Related]  

  • 35. [Are there differences in various statins?].
    Otto C; Schwandt P
    Internist (Berl); 1998 Sep; 39(9):987-93. PubMed ID: 9788127
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dual lipid control without anti-atherosclerosis effect].
    Einecke D
    MMW Fortschr Med; 2008 Apr; 150(16):18, 20. PubMed ID: 18557109
    [No Abstract]   [Full Text] [Related]  

  • 37. Do statin drugs lower the risk of stroke?
    Sabharwal M; Por CP; Evans MF
    Can Fam Physician; 1998 May; 44():1003-4. PubMed ID: 9612584
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid-lowering therapy in patients with coronary artery disease: sex or age bias?
    Sgadari A; Incalzi RA; Onder G; Pedone C; Gambassi G
    Arch Intern Med; 2000 Sep; 160(17):2684-5. PubMed ID: 10999995
    [No Abstract]   [Full Text] [Related]  

  • 39. Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives.
    McKenna CJ; Sugrue DD
    Ir Med J; 1995; 88(6):191. PubMed ID: 8575912
    [No Abstract]   [Full Text] [Related]  

  • 40. [The IMPROVE-IT trial showed no favorable effects on well-defined and clinically relevant endpoints].
    Mascitelli L; Goldstein MR
    G Ital Cardiol (Rome); 2015 Dec; 16(12):739. PubMed ID: 26667950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.